Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
GSK
Manufacturing
GSK, Sanofi, CSL nab BARDA funding for bird flu shots
CSL Seqirus, Sanofi and GSK have collectively secured $72 million in BARDA funding to boost U.S. supply of bird flu vaccines.
Angus Liu
Oct 4, 2024 1:35pm
Pfizer offloads another tranche of Haleon shares for £2.4B
Oct 1, 2024 10:23am
ESMO, WCLC lung cancer data spark hope—and debate
Sep 27, 2024 8:58am
American Lung Association launches new GSK-backed RSV campaign
Sep 26, 2024 9:30am
Gilead leads Asian patient groups' drugmaker reputation rankings
Sep 25, 2024 10:40am
In battle with GSK's Nucala, AZ's Fasenra wins FDA nod for EGPA
Sep 18, 2024 11:46am
